A Study to Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017)

Status:
Completed

Trial end date:
2010-02-01

Target enrollment:

Participant gender:

The purpose of this study is to test the effect of MK-0941 as add-on therapy for participants taking metformin for type 2 diabetes.

Phase 2

Merck Sharp & Dohme Corp.

Glimepiride
Metformin